Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Vitamin D411 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00222 | 35178204 | Caspian J Intern Med | Effect of Oral and parenteral routes of vitamin D supplementation on serum 25(OH) vitamin D levels in patients with non-alcoholic fatty liver disease. | 2022 | Details |
A00317 | 35140487 | Diabetes Metab Syndr Obes | The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study. | 2022 | Details |
A00326 | 35134438 | Life Sci | Fluorene-9-bisphenol exposure decreases locomotor activity and induces lipid-metabolism disorders by impairing fatty acid oxidation in zebrafish. | 2022 | Details |
A00343 | 35127371 | Acta Pharm Sin B | Therapeutic regulation of autophagy in hepatic metabolism. | 2021 | Details |
A00380 | 35109946 | Nutr Res Rev | NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways. | 2021 | Details |
A00398 | 35101633 | Clin Gastroenterol Hepatol | Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A00401 | 35100585 | Ann Nutr Metab | Influences of vitamin D levels and vitamin D binding protein polymorphisms on non-alcoholic fatty liver disease risk in a Chinese population. | 2022 | Details |
A00403 | 35100057 | Metab Syndr Relat Disord | Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V. | 2022 | Details |
A00418 | 35092183 | Pediatr Obes | Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity. | 2022 | Details |
A00474 | 35068796 | J Clin Exp Hepatol | A Current Understanding of Bile Acids in Chronic Liver Disease. | 2021 | Details |
A00478 | 35067753 | Eur J Nutr | The effects of fish oil plus vitamin D3 intervention on non-alcoholic fatty liver disease: a randomized controlled trial. | 2022 | Details |
A00804 | 34959990 | Nutrients | Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance. | 2021 | Details |
A00805 | 34959901 | Nutrients | Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review. | 2021 | Details |
A01023 | 34900782 | J Diabetes Metab Disord | Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease. | 2021 | Details |
A01072 | 34878523 | Endocrinology | Adipose-specific VDR Deletion Leads to Hepatic Steatosis in Female Mice Fed a Low-Fat Diet. | 2022 | Details |
A01100 | 34869532 | Front Nutr | Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults. | 2021 | Details |
A01177 | 34839623 | Clin Mol Hepatol | Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients. | 2021 | Details |
A01182 | 34836382 | Nutrients | The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities. | 2021 | Details |
A01280 | 34803681 | Front Pharmacol | The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
A01346 | 34780030 | Hepatol Int | Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study. | 2021 | Details |
A01460 | 34740314 | Mol Med | Nuclear receptors: a bridge linking the gut microbiome and the host. | 2021 | Details |
A01497 | 34723254 | JPGN Rep | Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints. | 2021 | Details |
A01519 | 34710938 | Z Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures. | 2021 | Details |
A01564 | 34692725 | Front Med (Lausanne) | PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial. | 2021 | Details |
A01804 | 34609237 | Health Informatics J | Trend research of vitamin D receptor: Bibliometric analysis. | 2021 | Details |
A01822 | 34604270 | Front Nutr | Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. | 2021 | Details |
A01823 | 34603404 | Front Genet | Corrigendum: Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
A01890 | 34572279 | Biomedicines | Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States. | 2021 | Details |
A02042 | 34522493 | Cureus | The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
A02155 | 34484304 | Front Genet | Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
A02208 | 34459959 | Eur J Pediatr | Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial. | 2021 | Details |
A02264 | 34444431 | Int J Environ Res Public Health | Inverse Association between Serum 25-hydroxyvitamin D Levels and Risk of Suspected Non-Alcoholic Fatty Liver Disease in Obese Population. | 2021 | Details |
A02299 | 34431511 | Cochrane Database Syst Rev | Vitamin D supplementation for chronic liver diseases in adults. | 2021 | Details |
A02319 | 34421816 | Front Endocrinol (Lausanne) | Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
A02801 | 34234538 | Int J Gen Med | Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. | 2021 | Details |
A02844 | 34221537 | Liver Res | Vitamins and non-alcoholic fatty liver disease: A Molecular Insight⋆. | 2021 | Details |
A02917 | 34199258 | J Clin Med | The Association between Vitamin D and Nonalcoholic Fatty Liver Disease Assessed by Controlled Attenuation Parameter. | 2021 | Details |
A03166 | 34106515 | Clin Obes | A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease. | 2021 | Details |
A03422 | 34006273 | BMC Endocr Disord | Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients. | 2021 | Details |
A03509 | 33977096 | Can J Gastroenterol Hepatol | NAFLD and Infection, a Nuanced Relationship. | 2021 | Details |
A03537 | 33965368 | Arch Biochem Biophys | Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in rats. | 2021 | Details |
A03563 | 33953582 | Diabetes Metab Syndr Obes | Correlation Between 25-Hydroxyvitamin D Level and Cardiac Diastolic Dysfunction in Chinese Adults with Early-Onset Type 2 Diabetes Mellitus: A Cross-Sectional Study. | 2021 | Details |
A03773 | 33868609 | Gastroenterol Hepatol Bed Bench | Efficacy of vitamin D supplementation on adult patients with non-alcoholic fatty liver disease: a single-center experience. | 2021 | Details |
A03881 | 33833974 | Pediatr Gastroenterol Hepatol Nutr | Vitamin D Effect on Ultrasonography and Laboratory Indices and Biochemical Indicators in the Blood: an Interventional Study on 12 to 18-Year-Old Children with Fatty Liver. | 2021 | Details |
A03896 | 33827700 | BMC Pharmacol Toxicol | The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism. | 2021 | Details |
A03998 | 33794916 | Nutr J | Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study. | 2021 | Details |
A04061 | 33772908 | Biofactors | The role of biofactors in the prevention and treatment of age-related diseases. | 2021 | Details |
A04131 | 33746447 | J Clin Exp Hepatol | Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation. | 2020 | Details |
A04260 | 33685086 | Zhonghua Gan Zang Bing Za Zhi | [Role of 1, 25-dihydroxyvitamin D3 in liver lipid metabolism induced by methionine-choline-deficient diet in rats]. | 2021 | Details |
A04309 | 33671262 | Nutrients | A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model. | 2021 | Details |
A04340 | 33658438 | Endocr J | Association between serum 25-hydroxy vitamin D level and metabolic associated fatty liver disease (MAFLD)-a population-based study. | 2021 | Details |
A04545 | 33583934 | J Epidemiol | Association between nutrient patterns and fatty liver index: Baseline survey of the Japan Multi-Institutional Collaborative Cohort Study in Tokushima, Japan. | 2021 | Details |
A04597 | 33568925 | Diabetes Metab Syndr Obes | The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity. | 2021 | Details |
A04611 | 33564651 | Clin Nutr Res | Probiotic Yogurt Fortified with Vitamin D Can Improve Glycemic Status in Non-Alcoholic Fatty Liver Disease Patients: a Randomized Clinical Trial. | 2021 | Details |
A04660 | 33548473 | J Nutr Biochem | Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice. | 2021 | Details |
A04676 | 33545191 | J Pediatr | Hepatic Steatosis is Negatively Associated with Bone Mineral Density in Children. | 2021 | Details |
A04690 | 33541129 | Exp Biol Med (Maywood) | Effect of vitamin D3 supplementation on hepatic lipid dysregulation associated with autophagy regulatory AMPK/Akt-mTOR signaling in type 2 diabetic mice. | 2021 | Details |
A04860 | 33478287 | Scand J Gastroenterol | Low serum vitamin D level associated with incident advanced liver disease in the general population - a prospective study. | 2021 | Details |
A04992 | 33421970 | Turk J Med Sci | The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease | 2021 | Details |
A05068 | 33388736 | Orv Hetil | Sarcopenia - 2021: Pathophysiology, diagnosis, therapy | 2021 | Details |
A05191 | 33341312 | Clin Nutr | A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A05434 | 33257903 | Int J Endocrinol Metab | Effects of Vitamin D Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
A05566 | 33204675 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand? | 2020 | Details |
A05752 | 33132636 | World J Gastroenterol | Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis? | 2020 | Details |
A05767 | 33126575 | Nutrients | Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. | 2020 | Details |
A05950 | 33065985 | Nutrients | Genomics in Personalized Nutrition: Can You "Eat for Your Genes"? | 2020 | Details |
A05956 | 33061886 | Food Nutr Res | Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver disease. | 2020 | Details |
A06096 | 33009010 | AIDS | Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. | 2020 | Details |
A06165 | 32981283 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | [Effects of liraglutide combined with vitamin D on non-alcoholic fatty liver induced by high fat in mice and its mechanism]. | 2020 | Details |
A06210 | 32966467 | Food Funct | Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2020 | Details |
A06301 | 32936063 | J Am Coll Nutr | Correlating Circulating Vitamin D3 with Aspects of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Healthy Female Volunteers. | 2020 | Details |
A06345 | 32921203 | Expert Rev Proteomics | Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study. | 2020 | Details |
A06446 | 32879216 | Biol Pharm Bull | A Lipid-Based Nanocarrier Containing Active Vitamin D3 Ameliorates NASH in Mice via Direct and Intestine-Mediated Effects on Liver Inflammation. | 2020 | Details |
A06457 | 32875543 | J Physiol Biochem | Metabolite profiling of mice under long-term fructose drinking and vitamin D deficiency: increased risks for metabolic syndrome and nonalcoholic fatty liver disease. | 2020 | Details |
A06530 | 32839076 | Eur J Intern Med | Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study. | 2020 | Details |
A06573 | 32822325 | Orv Hetil | The potential role of organic and conventional yoghurt consumption in the treatment of non-alcoholic fatty liver disease | 2020 | Details |
A06635 | 32799832 | BMC Cancer | Quantified MRI and 25OH-VitD3 can be used as effective biomarkers for patients with neoadjuvant chemotherapy-induced liver injury in CRCLM? | 2020 | Details |
A06706 | 32774765 | World J Gastrointest Surg | Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study. | 2020 | Details |
A06764 | 32756082 | Medicine (Baltimore) | Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2020 | Details |
A07054 | 32639223 | Int J Vitam Nutr Res | Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population. | 2020 | Details |
A07124 | 32613718 | Diabetes Obes Metab | Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial. | 2020 | Details |
A07411 | 32510837 | Liver Int | Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity. | 2020 | Details |
A07434 | 32498337 | Nutrients | Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study. | 2020 | Details |
A07557 | 32444241 | Clin Nutr | Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery. | 2020 | Details |
A07651 | 32408667 | Int J Environ Res Public Health | The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease. | 2020 | Details |
A07705 | 32384501 | Medicine (Baltimore) | Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus: A protocol for a systematic review and meta-analysis. | 2020 | Details |
A08456 | 32104220 | Exp Ther Med | Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease. | 2020 | Details |
A08583 | 32051143 | J Biol Chem | Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease. | 2020 | Details |
A08594 | 32045698 | Biochim Biophys Acta Mol Cell Biol Lipids | Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action. | 2020 | Details |
A08788 | 31984787 | Am J Physiol Gastrointest Liver Physiol | Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD. | 2020 | Details |
A09036 | 31895886 | Eur J Gastroenterol Hepatol | Association of serum vitamin D level and nonalcoholic fatty liver disease: a meta-analysis. | 2020 | Details |
A09041 | 31892608 | Anticancer Res | Vitamin D in Preclinical Models of Fatty Liver Disease. | 2020 | Details |
A09043 | 31891747 | J Steroid Biochem Mol Biol | Association of nonalcoholic fatty liver disease with serum vitamin D levels in combination of physical fitness in korean older adults. | 2019 | Details |
A09095 | 31877961 | Nutrients | Switching to a Healthy Diet Prevents the Detrimental Effects of Western Diet in a Colitis-Associated Colorectal Cancer Model. | 2019 | Details |
A09268 | 31810868 | Clin Res Hepatol Gastroenterol | Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model. | 2019 | Details |
A09306 | 31797544 | Mol Nutr Food Res | Vitamin D Deficiency Induces Insulin Resistance and Re-Supplementation Attenuates Hepatic Glucose Output via the PI3K-AKT-FOXO1 Mediated Pathway. | 2020 | Details |
A09342 | 31784293 | Arch Pediatr | Feeding problems and gastrointestinal diseases in Down syndrome. | 2019 | Details |
A09395 | 31761548 | Nutr Metab Cardiovasc Dis | Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort. | 2019 | Details |
A09421 | 31756344 | Life Sci | Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway. | 2019 | Details |
A09460 | 31737175 | Oxid Med Cell Longev | Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. | 2019 | Details |